These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2387529)

  • 21. The effect of amifostine on the in vitro cytotoxicity of chemotherapeutic agents in three epithelial ovarian carcinoma cell lines.
    Ng TY; Ngan HY; Cheng DK; Wong LC
    Gynecol Oncol; 1999 Nov; 75(2):194-7. PubMed ID: 10525371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
    Jinushi K; Hirabayashi N; Kirihara Y; Takagami S; Ryuji K; Yorishima T; Nishiyama M; Noso Y; Toge T
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2235-9. PubMed ID: 2122811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
    Bergerat JP; Green C; Drewinko B
    Cancer Biochem Biophys; 1979; 3(4):173-80. PubMed ID: 575983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
    Mistry P; Kelland LR; Loh SY; Abel G; Murrer BA; Harrap KR
    Cancer Res; 1992 Nov; 52(22):6188-93. PubMed ID: 1423261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A correlation of cell cycle perturbations with chemosensitivity in human ovarian cancer cells exposed to cytotoxic drugs in vitro.
    Petru E; Sevin BU; Haas J; Ramos R; Perras J
    Gynecol Oncol; 1995 Jul; 58(1):48-57. PubMed ID: 7789890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assay.
    Untch M; Sevin BU; Perras JP; Angioli R; Untch A; Hightower RD; Koechli O; Averette HE
    Gynecol Oncol; 1994 Apr; 53(1):44-9. PubMed ID: 7909786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitro.
    Untch M; Sevin BU; Perras JP; Angioli R; Baibl A; Nguyen HN; Hightower RD; Averette HE
    Gynecol Oncol; 1992 Nov; 47(2):172-8. PubMed ID: 1468695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
    Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assay.
    Koechli OR; Sevin BU; Perras JP; Angioli R; Untch M; Steren A; Ramachandran C; Averette HE
    Oncology; 1994; 51(6):552-8. PubMed ID: 7970502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of the novel chemotherapeutic agents U-73,975, U-77,779, and U-80,244 in gynecologic cancer cell lines.
    Hightower RD; Sevin BU; Perras J; Nguyen H; Angioli R; Untch M; Averette H
    Cancer Invest; 1993; 11(3):276-82. PubMed ID: 8485650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
    Yamashita K; Urakami A; Kubozoe T; Ikeda M; Hirabayashi Y; Yamamura M; Iki K; Akiyama T; Matsumoto H; Hirai T; Sadahira Y; Tsunoda T
    Int J Clin Oncol; 2005 Oct; 10(5):328-32. PubMed ID: 16247659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chemotherapeutic agents on the growth of rat bladder cancer, BC-47.
    Iwaguchi T; Kitagawa H
    Gan; 1978 Feb; 69(1):123-6. PubMed ID: 76584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing.
    Sevin BU; Peng ZL; Perras JP; Ganjei P; Penalver M; Averette HE
    Gynecol Oncol; 1988 Sep; 31(1):191-204. PubMed ID: 3410347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
    Kurbacher CM; Cree IA
    Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of cisplatin cytotoxicity by methylxanthines in vitro.
    Petru E; Boike G; Sevin BU
    J Cancer Res Clin Oncol; 1990; 116(5):431-3. PubMed ID: 2229131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro.
    Kangas L; Grönroos M; Nieminen AL
    Med Biol; 1984; 62(6):338-43. PubMed ID: 6543460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.